$AUNA

AUNA S.A. (AUNA): Financial results for Q2 2026

AUNA S.A. (AUNA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Auna Announces 2Q26 Financial Results A consecutive quarter of strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by service mix across the segments Luxembourg, August 18, 2026 – Auna (NYSE: AUNA) (“Auna” or the “Company”) , a lea

Original reporting
Published Aug 18, 2026, 9:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 6:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AUNA
Neutral
high confidence
Mentioned
$AUNA
Relevance
7/10
alphai data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$AUNANeutralMed
01

Why it matters

The earnings release provides fresh financial metrics and expansion updates that can influence stock valuation.

02

Market read

First report of Q2 2026 earnings for AUNA, offering actionable data for traders.

03

What to watch

Potential regulatory changes in Peru and Colombia and currency fluctuations may affect future results.

Relevance 7/10Novelty 7/10Timing: post‑earnings release Aug 18 2026

Background

Auna is a leading Latin American healthcare platform listed on NYSE, providing hospital and oncology services.

Company-level read

Ticker impact

$AUNANeutralHigh confidence
Context

Auna reported Q2 2026 results with revenue up 9% YoY and adjusted EBITDA down 9% YoY, plus guidance and operational updates.

Expected impact

Potential short-term volatility as investors digest mixed earnings; upside if guidance holds, downside if margin concerns dominate.

Evidence & confidence

First disclosure of earnings with detailed numbers and operational outlook provides clear trading signals.

Market effects

Highlights growth and margin dynamics in Latin American healthcare sector.

Positive for regional markets in Mexico, Peru, Colombia as healthcare demand rises.

Limited to investors focused on emerging‑market healthcare exposure.

Counterpoint

Margin compression and service mix risks could outweigh revenue growth, suggesting a short bias.

Key entities

  • Abraham Galán

    New Chief Technology Officer appointed Aug 3 2026.

Related articles

$AUNAMed

Auna (AUNA) Q2 2026 Earnings Call Transcript

Auna (AUNA) reported Q2 2026 results with 9% revenue growth driven by volume and higher complexity services. Adjusted EBITDA declined 9% due to margin pressures in Mexico and Colombia, and billing penalties in Peru. Mexico saw 7% surgery and 20% oncology volume growth, while Peru achieved 8% revenue growth. Colombia's adjusted EBITDA increased 18% sequentially. Leverage decreased to 3.6x, and cash increased 43% year-over-year.

$AUNAMed

Auna Q2 Earnings Call Highlights

Auna reported Q2 revenue growth in Mexico (4% YoY), Peru (8%), and Colombia (13%), but adjusted EBITDA varied. Mexico's EBITDA declined 16% YoY due to investments, while Peru's was flat due to billing penalties. Colombia's EBITDA fell 12% YoY but rose 18% sequentially. The company reaffirmed its full-year guidance, expecting 12% FX-neutral revenue growth and adjusted EBITDA growth toward the low end of its 10-14% target range, excluding Peru's billing penalties. Cash flow and leverage improved,

$AUNAMed

Auna S.A. Q2 2026 Earnings Call Summary

Auna S.A. reported Q2 2026 revenue growth of 9%, driven by high-complexity services, with adjusted EBITDA declining 9% due to investment costs. Management reaffirmed full-year revenue guidance of 12% growth and expects EBITDA growth at the low end of 10-14%. Free cash flow increased 181% due to working capital management. The company faces short-term penalties in Peru but anticipates improvements in profitability and cash flow.

$AUNAMedAI 9/10

Auna S.A.: Auna Announces 2Q26 Financial Results

Auna S.A. (NYSE: AUNA) reported 2Q26 results with revenue up 9% FX-neutral to S/1,238 million, but Adjusted EBITDA down 9% FX-neutral to S/227 million. Operating cash flow and free cash flow rose 45% and 181% YoY, respectively. The company attributed EBITDA declines to service mix and cost pressures across its Latin American markets. Auna reaffirmed its full-year revenue guidance of 12% growth and expects Adjusted EBITDA growth at the low end of its 10-14% range.

$GCOMed

102-year-old mall retailer quietly closes 25 stores

Genesco (GCO) closed 25 stores, including 17 Journeys locations, in Q2 fiscal 2027, per its earnings release. Net sales fell 3% YoY to $530M, with comparable sales down 1%. The company is shifting away from malls and remodeling stores to boost sales, with 4.0 Journeys stores showing 25% higher sales.